Genome-Wide Association Study for Glucocorticoid-Induced Ocular Hypertension [0.03%]
糖皮质激素引起的眼压升高的全基因组关联研究
Jyoti Lama,Renee Liu,Alicia Huerta-Chagoya et al.
Jyoti Lama et al.
Purpose: To identify genetic variants associated with glucocorticoid (GC)-induced intraocular pressure (IOP) change using genome-wide association study (GWAS) and whole exome sequencing (WES) analyses. ...
Assessing Polypoidal Choroidal Vasculopathy-Related OCT Features in the TENAYA and LUCERNE Trials [0.03%]
评估TENAYA和LUCERNE试验中息肉状脉络膜血管病变相关的OCT特征
Kelvin Yi Chong Teo,Philippe Margaron,Timothy Y Y Lai et al.
Kelvin Yi Chong Teo et al.
Objective: To describe OCT features associated with polypoidal choroidal vasculopathy (PCV) in the TENAYA and LUCERNE clinical trial cohorts. Design: ...
Quantitative Analysis of Choroidal Thickness and Blood Flow in Thyroid-Associated Ophthalmopathy Using Ultra-Widefield Swept-Source OCT Angiography [0.03%]
甲状腺相关性眼病的脉络膜厚度和血流的定量分析——使用超广角扫频源光学相干断层扫描血管成像技术
Guodong Liu,Kunhua Jiang,Mingyang Wang et al.
Guodong Liu et al.
Objective: To quantitatively analyze choroidal thickness and blood flow in thyroid-associated ophthalmopathy (TAO) using ultra-widefield swept-source OCT angiography (UWF SS-OCTA), and to characterize differences among dy...
Epiretinal Membrane Is Associated with Acquired Vitelliform Lesion Morphometrics in Intermediate Age-Related Macular Degeneration [0.03%]
玻璃膜疣形态计量学与视网膜前膜的相关性研究中间年龄相关性黄斑变性的患者
Alberto Quarta,Rouzbeh Abbasgholizadeh,Jianfeng Huang et al.
Alberto Quarta et al.
Purpose: To investigate the impact of epiretinal membrane (ERM) on the structural characteristics of acquired vitelliform lesions (AVLs) in eyes with intermediate age-related macular degeneration (iAMD). ...
Multisource Machine Learning Model for Detecting Referral-Warranted Retinopathy of Prematurity [0.03%]
用于检测需转诊治疗早产儿视网膜病变的多数据来源机器学习模型
Xinwei Luo,Yong Chen,Bowen Ying et al.
Xinwei Luo et al.
Purpose: To develop a multisource machine learning model for detecting referral-warranted retinopathy of prematurity (RW-ROP) using retinal images and demographics. ...
Association of Tirzepatide versus Glucagon-Like Peptide-1 Receptor Agonists with Incident Glaucoma in Patients with Type 2 Diabetes: A Retrospective Cohort Study [0.03%]
tirzepatide与GLP-1受体激动剂相比新发青光眼的关联性：2型糖尿病患者的回顾性队列研究
Ssu-Yu Pan,Chien-Hsiang Weng,Yi-Jing Sheen et al.
Ssu-Yu Pan et al.
Objective: To assess the comparative risk of glaucoma among patients with type 2 diabetes mellitus (T2DM) treated with tirzepatide versus glucagon-like peptide-1 receptor agonists (GLP-1RAs). ...
Regional Biomechanical and Topographic Changes after Transepithelial vs. Epithelium-off Continuous Accelerated Corneal Cross-linking in Keratoconus: Updated Stress-Strain Index as a Superior Biomarker [0.03%]
原 epithelium versus去上皮连续加速角膜交联治疗角膜扩张的区域生物力学和地形变化：更新的应力应变指数作为更佳生物标志物
BangXun Mao,ChangChang He,Qian Ye et al.
BangXun Mao et al.
Purpose: To compare regional biomechanical and topographic outcomes between transepithelial (Epi-on) and epithelium-off (Epi-off) continuous accelerated corneal cross-linking (ACXL) in keratoconus. ...
Ashley Polski,Ben J Brintz,Rachel Hess et al.
Ashley Polski et al.
Purpose: Glaucoma providers longitudinally integrate clinical data to inform treatment decisions. While information overload is an increasingly well-recognized issue in medicine, the volume of information associated with ...
Large Language Models for Ophthalmology Training in China: A Prospective Evaluation [0.03%]
中国眼科培训的大规模语言模型：一项前瞻性评价
Zuhui Zhang,Changke Huang,Xinxin Yu et al.
Zuhui Zhang et al.
Purpose: This study explored large language models (LLMs) as a scalable solution to the global shortage and uneven distribution of ophthalmologists, particularly their actual effectiveness and potential risks in ophthalmi...
Tropomyosin-Related Kinase Receptor Type B Agonism in Geographic Atrophy-The Translational Challenges from Preclinical Data to a First-in-Human Trial [0.03%]
tropomyosin受体b激动剂治疗地理性萎缩：从临床前数据到首次人体试验的转化挑战
David Brown,Oliver Zeitz,Clare Bailey et al.
David Brown et al.
Objective: To report results of the first-in-human trial of intravitreal tropomyosin-related kinase receptor type B (TrkB) agonist BI 754132 in participants with geographic atrophy (GA). To discuss BI 754132 clinical data...